SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-027277
Filing Date
2023-08-09
Accepted
2023-08-09 08:52:24
Documents
21
Period of Report
2023-08-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 70636
2 ex10-1.htm EX-10.1 65272
3 ex10-2.htm EX-10.2 370962
4 ex10-3.htm EX-10.3 495629
5 ex10-4.htm EX-10.4 141436
6 ex99-1.htm EX-99.1 44734
7 ex10-2_001.jpg GRAPHIC 230992
8 ex10-2_002.jpg GRAPHIC 107114
9 ex99-1_001.jpg GRAPHIC 5059
10 ex99-1_002.jpg GRAPHIC 3863
  Complete submission text file 0001493152-23-027277.txt   2017466

Data Files

Seq Description Document Type Size
11 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rspi-20230803.xsd EX-101.SCH 3018
12 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rspi-20230803_lab.xml EX-101.LAB 34240
13 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rspi-20230803_pre.xml EX-101.PRE 22361
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3040
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 231153544
SIC: 2834 Pharmaceutical Preparations